The long-term clinical results of medications approved by the Food and Drug Administration (FDA) will be improved by the rapidly growing field of protein therapies. Through the creation of intelligent, stimulus-responsive pharmacological systems, protein engineering has the potential to change the metabolic drug landscape. It involves creating beneficial and/or valuable proteins. Using this cutting-edge technique, protein therapeutics can be created to treat a variety of chronic conditions, including cancer, diabetes, and other autoimmune illnesses.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5272
By the end of 2022, the worldwide protein engineering market is anticipated to generate US$2,238.5 Mn in revenue.
Over the course of the forecast period, an increase in the frequency of chronic illnesses and other autoimmune diseases is anticipated to support the expansion of the worldwide protein engineering market. For instance, therapeutic proteins are frequently utilised to treat autoimmune disorders, cancer, and HIV. The usage of monoclonal bodies has rapidly expanded as chronic diseases like cancer and other autoimmune disorders are becoming more common. Among the most important types of therapeutic proteins are monoclonal antibodies, IFN, and cytokines.
The primary causes of death and disability worldwide are chronic diseases. The American Cancer Society predicts that there will be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the United States in 2022.
Significant development prospects for participants in the global protein engineering market are anticipated as the usage of protein medications over non-protein drugs rises. For instance, a rapidly growing category of FDA-approved medications that will eventually enhance clinical results is protein therapies. A variety of chronic disorders, including cancer and other autoimmune diseases, may be treated with protein medicines. As a result, during the projected period, it is anticipated that more people would choose protein medications over non-protein drugs, creating attractive growth potential for market participants.
Some significant challenges that are anticipated to impede the growth of the protein engineering market include the high development costs of therapeutic proteins and a shortage of qualified specialists. For instance, there is a lack of skilled people in rich and developing nations despite significant investments in the protein engineering sector (government financing for protein engineering and supportive government efforts). For instance, professional and trained personnel are required to carry out the procedures for sophisticated protein engineering technologies such as high throughput screening and the building of a protein variant library.
Protein engineering is being utilised to create vaccines and for quick, simple testing of coronavirus antibodies all around the world as a result of the spike in COVID-19 prevalence or incidence. The development of COVID-19 treatments can be accelerated by new protein engineering techniques. In addition, the usage of protein engineering tools and techniques for creating COVID-19 medicines and vaccines, as well as rising research and development efforts for protein-based treatments, are anticipated to fuel market expansion.
The global protein engineering market was estimated to be worth US$ 1,936.7 Mn in 2021 and is anticipated to grow at a CAGR of 15.6% between 2022 and 2028 to reach US$ 5,355.8 Mn.
Monoclonal antibodies, a subset of the protein type segment that accounted for 38.5% of the market for global protein engineering in terms of value in 2021, are anticipated to continue growing throughout the forecast period due to rising product approval and launches.
The rise in the preference for protein medications over non-protein drugs is a factor in the expansion of the market for protein engineering. The main causes of this rising popularity are the expanded options for protein treatments and the positive long-term clinical results associated with protein medications, both of which are encouraging their use globally. The usage of protein engineering tools has significantly increased as a result of this exceptional demand, and this trend is anticipated to continue during the projected period.
Thermo Fisher Scientific Inc., Codexis Inc., PerkinElmer, Inc., Abzena, Ltd., Bio-Rad Laboratories Inc., Enantis s.r.o., Agilent Technologies, GenScript Biotech Corp., Bruker Corporation, and Waters Corporation, are a few of the major companies active in the worldwide protein engineering market.
Eli Lilly & Company purchased Protomer Technologies in July 2021. With Protomer’s revolutionary technology programme of glucose-sensing insulin based on its patented molecular engineering of protein sensors (MEPS) platform, Eli Lilly will be able to improve its diabetes portfolio and pipeline thanks to this acquisition.
The cd25 monoclonal antibody was a new product introduced to the market by Creative Biolabs in 2019. The antibody can be utilised extensively in situations like the body rejecting an organ after donation, particularly kidney transplants.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5272
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Protein Engineering Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Protein Engineering Industry Impact
Chapter 2 Global Protein Engineering Competition by Types, Applications, and Top Regions and Countries
2.1 Global Protein Engineering (Volume and Value) by Type
2.3 Global Protein Engineering (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Protein Engineering Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Protein Engineering Market Analysis
Chapter 6 East Asia Protein Engineering Market Analysis
Chapter 7 Europe Protein Engineering Market Analysis
Chapter 8 South Asia Protein Engineering Market Analysis
Chapter 9 Southeast Asia Protein Engineering Market Analysis
Chapter 10 Middle East Protein Engineering Market Analysis
Chapter 11 Africa Protein Engineering Market Analysis
Chapter 12 Oceania Protein Engineering Market Analysis
Chapter 13 South America Protein Engineering Market Analysis
Chapter 14 Company Profiles and Key Figures in Protein Engineering Business
Chapter 15 Global Protein Engineering Market Forecast (2022-2028)
Chapter 16 Conclusions
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5272
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027